Ligand · WBV
WBV · (2S)-tert-butoxy{4-(4-chlorophenyl)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}acetic acid
WBV, (2S)-tert-butoxy{4-(4-chlorophenyl)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}acetic acid (C27 H31 Cl N4 O3, 495.0 g/mol), in the MolNFT structures on GenesisL1: bound in 5 records (4 PDB…
- Component
- WBV
- Formula
- C27 H31 Cl N4 O3
- Class
- ligand
- Structures
- 5
- PDB entries
- 4
Binding sites
WBV in 5 structures; the first of them:
- 7KE0 · HIV-1 Integrase catalytic core domain complexed with allosteric inhibitor STP03-0404 · WBV A301 · binds GLN95, ALA98, TYR99, LEU102, THR124, THR125, ALA128, ALA129 and 1 more
- 8A1Q · HIV-1 Integrase Catalytic Core Domain and C-Terminal Domain in Complex with Allosteric… · WBV B308 · binds GLN168, ALA169, GLU170, HIS171, THR174, MET178, TYR226, TRP235 and 11 more
- 8S9Q · HIV-1 Integrase Catalytic Core Domain (CCD) F185H Mutant Complexed with STP03-0404 · WBV A301 · binds GLN168, ALA169, GLU170, HIS171, LYS173, THR174, MET178
- 8T5A · HIV-1 Integrase Catalytic Core Domain (CCD) F185H/Y99H/A128T Mutant Complexed with… · WBV A301 · binds GLN168, ALA169, GLU170, HIS171, LYS173, THR174
- 7KE0 · HIV-1 integrase catalytic core domain complexed with allosteric inhibitor STP03-0404 · WBV A301 · binds GLN95, TYR99, LEU102, THR124, THR125, ALA128, ALA129, TRP132
Residues it binds most
ALA 6, THR 6, GLN 6, TRP 4, TYR 4, GLU 4, HIS 4, LEU 4, LYS 4, MET 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.